期刊文献+

血管活性药物评分联合APACHE II评分对血流感染后脓毒性休克患者预后的预测价值

Prognostic Value of Vasoactive Inotropic Score Combined with APACHE II Score in Patients with Septic Shock after Bloodstream Infection
下载PDF
导出
摘要 目的:探讨血管活性药物评分(vasoactive inotropic score, VIS)联合急性生理与慢性健康评分(APACHE II)对血流感染后脓毒性休克患者结局的预测价值,为临床提供参考。方法:采用回顾性研究方法,通过收集2020年1月至2022年12月安徽医科大学附属合肥医院重症医学科收治的185例脓毒性休克患者的临床资料,根据28 d转归情况,分为存活组95例和死亡组90例,记录所有患者性别、年龄、相关血液检测指标、SOFA评分、24小时内急性生理与慢性健康评分(APACHE II)及24小时内最大血管活性药物评分(VISmax24)等信息,采用单因素分析筛选脓毒性休克患者的相关危险因素,多因素logistic回归分析影响脓毒性休克患者预后的独立危险因素,采用受试者工作特征(receiver op-erating characteristic, ROC)曲线下面积(area under curve, AUC)分析各指标的诊断价值。结果:单因素分析结果表明:死亡组的APACHE II评分(24.30 ± 5.157)、VISmax24 [100.0 (53.5, 121.0)]明显高于存活组(P max24联合APACHE II评分(AUC = 0.848, 95% CI: 0.792~0.905),较单一的APACHE II评分(AUC = 0.729, 95% CI: 0.655~0.802)、VISmax24 (AUC = 0.783, 95% CI: 0.709~0.856)、乳酸(AUC = 0.665, 95% CI: 0.587~0.743)、SOFA (AUC = 0.680, 95% CI: 0.602~0.758)预测价值更高。结论:VISmax24联合APACHE II评分能更有效预测血流感染后脓毒性休克患者的预后。 Objective: To study the predictive value of vasoactive-inotropic score (VIS) combined with acute physiology and chronic health evaluation (APACHE II) score for the outcome of patients with septic shock after the bloodstream infections, provide reference for clinical. Methods: A retrospective study was conducted to collect the clinical data of 185 patients with septic shock admitted to the Department of Intensive Care Medicine of Hefei Hospital Affiliated to Anhui Medical University from January 2020 to December 2022. According to the outcome of 28 days, 95 patients were divided in-to a survival group and 90 patients were divided into a death group. Gender, age, relevant blood test indicators, SOFA score, APACHE II score within 24 hours and the maximum vasoactive-inotropic score within 24 hours which were expressed as VISmax24 of all patients were recorded. Single factor analysis was used to screen the related risk factors of patients with septic shock. Multivariate lo-gistic regression was used to analyze the independent risk factors affecting the prognosis of patients with septic shock. The area under receiver operating characteristic curve was used to analyze the diagnostic value of each indicator. Results: Univariate analysis showed that APACHE II score (24.30 ± 5.157) and VISmax24 [100.0 (53.5, 121.0)] in the death group were significantly higher than those in the survival group (P max24 combined with APACHE II rating (AUC = 0.848, 95% CI: 0.792~0.905), compared with single APACHE II rating (AUC = 0.729, 95% CI: 0.655~0.802), VISmax24 (AUC = 0.783, 95% CI: 0.709~0.856), lactic acid (AUC = 0.665, 95% CI: 0.587~0.743), SOFA (AUC = 0.680, 95% CI: 0.602~0.758) had higher predictive value. Conclusion: VISmax24 combined with APACHE II score can predict the prognosis of patients with septic shock after bloodstream infection more effectively.
出处 《临床医学进展》 2024年第2期3114-3121,共8页 Advances in Clinical Medicine
  • 相关文献

参考文献4

二级参考文献26

  • 1Kofoed K,Andersen O,Kronborg G,et al.Use of plasma C-reactive protein,procalcitonin,neutrophils,macrophage migration inhibitory factor,soluble urokinase-type plasminogen activator receptor,and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections:a prospective study[J].Crit Care,2007,11(2):R38.
  • 2Christophe L,Sophie A,Karim Z B,et al.Interpretation of C-Reactive Protein Concentrations in Critically Ⅲ Patients[J].Biomed Res Int,2013,28:1-11.
  • 3GiamareUos-Bourboulis E J,Tsangaris I,Kanni T,et al.Procalcitonin as an early indicator of outcome in sepsis:a prospective observational study[J].J Hosp Infect,2011,77(1):58-63.
  • 4Schuetz P,Albrich W,Mueller B.Procalcitonin for diagnosis of infection and guide to antibiotic decisions:past,present and future[J].BMC Med,2011,9:107.
  • 5Levy M M,Fink M P,Marshall J C,et al.2001 SCCM/ESICM/ACCP/ATS/SIS International sepsis definitions conference[J].Crit Care Med,2003,31(4):1250-1256.
  • 6Knaus W A,Draper E A,Wagner D P,et al.APACHE Ⅱ:a severity of disease classification system[J].Crit Care Med,1985,13(10):818-829.
  • 7Le Gall J R,Lemeshow S,Saulnier F.A new Simplified Acute Physiology Score(SAPS Ⅱ) based on a European/North American multicenter study[J].JAMA,1993,270(24):2957-2963.
  • 8Sari K,Milja H,Ville P,et al.Predictive value of procalcitonin decrease in patients with severe sepsis:a prospective observational study[J].Critical Care,2010,14(6):R205.
  • 9Nobre V,Harbarth S,Graf J D,et al.Use of procalcitonin to shorten antibiotic treatment duration in septic patients:a randomized trial[J].Am J Respir Crit Care Med,2008,177(5):498-505.
  • 10Clec'h C,Ferriere F,Karoubi P,et al.Diagnostic and prognostic value of procalcitonin in patients with septic shock[J].Crit Care Med,2004,32(5):1166-1169.

共引文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部